Autoantibody landscape in patients with advanced prostate cancer

BACKGROUND: Autoantibody responses in cancer are of great interest, as they may be concordant with T-cell responses to cancer antigens or predictive of response to cancer immunotherapies. Thus, we sought to characterize the antibody landscape of metastatic castration-resistant prostate cancer (mCRPC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Chen, William S., Haynes, Winston A., Waitz, Rebecca, Kamath, Kathy, Vega-Crespo, Agustin, Shrestha, Raunak, Zhang, Minlu, Foye, Adam, Carretero, Ignacio Baselga, Perez, Ivan Garcilazo, Zhang, Meng, Zhao, Shuang G., Sjöström, Martin, Quigley, David A., Chou, Jonathan, Beer, Tomasz M., Rettig, Matthew, Gleave, Martin, Evans, Christopher P., Lara, Primo, Chi, Kim N., Reiter, Robert E., Alumkal, Joshi J., Ashworth, Alan, Aggarwal, Rahul, Small, Eric J., Daugherty, Patrick S., Ribas, Antoni, Oh, David Y., Shon, John C., Feng, Felix Y.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7710628/
https://ncbi.nlm.nih.gov/pubmed/32967941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-1966
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars